KJIM :: Korean Journal of Internal Medicine

Temporal trends of pharmacologic treatments for tuberculosis and multidrug resistant tuberculosis following dissemination of treatment guidelines in South Korea

Han Eol Jeong, Junyeong Choi, In-Sun Oh, Hyunjin Son, Seung Hun Jang, Sun-Young Jung, Ju-Young Shin

Journal of Microbiology, Immunology and Infection.2022; 55(5): 917. CrossRef

The treatment effect of Levofloxacin, Moxifloxacin, and Gatifloxacin contained in the conventional therapy regimen for pulmonary tuberculosis: Systematic review and network meta-analysis

9 months of delamanid, linezolid, levofloxacin, and pyrazinamide versus conventional therapy for treatment of fluoroquinolone-sensitive multidrug-resistant tuberculosis (MDR-END): a multicentre, randomised, open-label phase 2/3 non-inferiority trial in So

Jeongha Mok, Myungsun Lee, Deog Kyeom Kim, Ju Sang Kim, Byung Woo Jhun, Kyung-Wook Jo, Doosoo Jeon, Taehoon Lee, Ji Yeon Lee, Jae Seuk Park, Seung Heon Lee, Young Ae Kang, Jung-Kyu Lee, Nakwon Kwak, Joong Hyun Ahn, Tae Sun Shim, Song Yee Kim, Seungmo Kim,

Meta-analysis on Effectiveness and Safety of Moxifloxacin in Treatment of Multidrug Resistant Tuberculosis in Adults

Molecular dynamics simulation and binding free energy studies of novel leads belonging to the benzofuran class inhibitors of Mycobacterium tuberculosis Polyketide Synthase 13

Jorddy N. Cruz, José F. S. Costa, André S. Khayat, Kamil Kuca, Carlos A. L. Barros, A. M. J. C. Neto

Journal of Biomolecular Structure and Dynamics.2019; 37(6): 1616. CrossRef

Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection

Mohammad H. Al-Shaer, Wael A. Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, J. Peter Cegielski, Russell R. Kempker, Scott K. Heysell, Charles A. Peloquin

Antimicrobial Agents and Chemotherapy.2019;[Epub] CrossRef

Comparing efficacies of moxifloxacin, levofloxacin and gatifloxacin in tuberculosis granulomas using a multi-scale systems pharmacology approach

Elsje Pienaar, Jansy Sarathy, Brendan Prideaux, Jillian Dietzold, Véronique Dartois, Denise E. Kirschner, Jennifer J. Linderman, Scott L Diamond

PLOS Computational Biology.2017; 13(8): e1005650. CrossRef

Effect of Extract on Osteoclast Differentiation and Bone-pit Formation

Journal of Korean Medicine.2017; 38(3): 59. CrossRef

An updated systematic review and meta-analysis for treatment of multidrug-resistant tuberculosis

European Respiratory Journal.2017; 49(3): 1600803. CrossRef

SpecificgyrAgene mutations predict poor treatment outcome in MDR-TB

L. Rigouts, N. Coeck, M. Gumusboga, W. B. de Rijk, K. J. M. Aung, M. A. Hossain, K. Fissette, H. L. Rieder, C. J. Meehan, B. C. de Jong, A. Van Deun

Journal of Antimicrobial Chemotherapy.2016; 71(2): 314. CrossRef

Development and validation of LC-ESI-MS/MS method for analysis of moxifloxacin and levofloxacin in serum of multidrug-resistant tuberculosis patients: Potential application as therapeutic drug monitoring tool in medical diagnosis

Sung Joong Lee, Kebede Taye Desta, Seok Yong Eum, Veronique Dartois, Sang Nae Cho, Dong-Won Bae, Sung Chul Shin

Journal of Chromatography B.2016; 1009-1010: 138. CrossRef

Impact of Fluoroquinolone Exposure Prior to Tuberculosis Diagnosis on Clinical Outcomes in Immunocompromised Patients

Ju Young Lee, Hyun Jung Lee, Yong Kyun Kim, Shinae Yu, Jiwon Jung, Yong Pil Chong, Sang-Oh Lee, Sang-Ho Choi, Tae Sun Shim, Yang Soo Kim, Jun Hee Woo, Sung-Han Kim

Antimicrobial Agents and Chemotherapy.2016; 60(7): 4005. CrossRef

Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis

Huaidong Wang, Xiaotian Zhang, Yuanxiang Bai, Zipeng Duan, Yan Lin, Guoqing Wang, Fan Li

Journal of Clinical Bioinformatics.2015;[Epub] CrossRef

Diagnosis and Treatment of Multidrug-Resistant Tuberculosis

Korean Journal of Medicine.2015; 88(5): 509. CrossRef

Comparison of Levofloxacin versus Moxifloxacin for Multidrug-Resistant Tuberculosis

Won-Jung Koh, Seung Heon Lee, Young Ae Kang, Chang-Hoon Lee, Jae Chol Choi, Jae Ho Lee, Seung Hun Jang, Kwang Ha Yoo, Ki Hwan Jung, Ki Uk Kim, Sang Bong Choi, Yon Ju Ryu, Kyung Chan Kim, Soojung Um, Yong Soo Kwon, Yee Hyung Kim, Won-Il Choi, Kyeongman Jeo

American Journal of Respiratory and Critical Care Medicine.2013; 188(7): 858. CrossRef

Medical Treatment of Pulmonary Multidrug-Resistant Tuberculosis

Infection & Chemotherapy.2013; 45(4): 367. CrossRef

Pseudo-uvéite sévère associée à l’utilisation de moxifloxacine

A. Duncombe, J. Gueudry, N. Massy, C. Chapuzet, I. Gueit, M. Muraine

Journal Français d'Ophtalmologie.2013; 36(2): 146. CrossRef

Interferon‐gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis

International Journal of Rheumatic Diseases.2013; 16(3): 279. CrossRef

Comparative roles of moxifloxacin and levofloxacin in the treatment of pulmonary multidrug-resistant tuberculosis: a retrospective study

International Journal of Antimicrobial Agents.2013; 42(1): 36. CrossRef

Risk Factors for Poor Treatment Outcomes in Patients with MDR-TB and XDR-TB in China: Retrospective Multi-Center Investigation

Shenjie Tang, Shouyong Tan, Lan Yao, Fujian Li, Li Li, Xinzhi Guo, Yidian Liu, Xiaohui Hao, Yanqiong Li, Xiuxiu Ding, Zhanjun Zhang, Li Tong, Jianan Huang, Katalin Andrea Wilkinson

Fluoroquinolones for treating tuberculosis (presumed drug-sensitive)

Lilia E Ziganshina, Albina F Titarenko, Geraint R Davies

Cochrane Database of Systematic Reviews.2013;[Epub] CrossRef

Treatment of Refractory Mycobacterium avium Complex Lung Disease with a Moxifloxacin-Containing Regimen

Won-Jung Koh, Goohyeon Hong, Su-Young Kim, Byeong-Ho Jeong, Hye Yun Park, Kyeongman Jeon, O Jung Kwon, Seung-Heon Lee, Chang Ki Kim, Sung Jae Shin

Antimicrobial Agents and Chemotherapy.2013; 57(5): 2281. CrossRef

New treatment options for multidrug-resistant tuberculosis

Stephen K. Field, Dina Fisher, Julie M. Jarand, Robert L. Cowie

Therapeutic Advances in Respiratory Disease.2012; 6(5): 255. CrossRef